We represented Sofinnova HealthQuest Partners in its investment in LineaGen Inc. LineaGen secured $15.8 million in the Series C round of financing led Sofinnova HealthQuest and joined by Mountain Group Capital, Petra Capital Partners and others.

Lineagen’s mission is to accelerate and enhance the diagnostic evaluation of medical conditions so that the best possible outcomes can be achieved for patients and their families.

HealthQuest Capital makes go-to-market and early growth investments in innovative healthcare companies that are improving both patient outcomes and healthcare economics.